Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies

Biomolecules. 2022 Jun 9;12(6):809. doi: 10.3390/biom12060809.

Authors

Giuseppe Mandraffino¹, Alessandro Mattina², Roberto Scicali³

Affiliations

¹ Internal Medicine Unit, Lipid Center, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.
² Diabetes and Islet Transplantation Unit, Department of Diagnostic and Therapeutic Services, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), UPMC Italy, 90127 Palermo, Italy.
³ Department of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.

Abstract

Atherosclerosis is a long-term damaging process, and its progression leads to cardiovascular system injury [...].

Publication types

Editorial

MeSH terms

Atherosclerosis*
Biomarkers
Cardiovascular Diseases*
Humans
Risk Factors

Substances

Biomarkers

Grants and funding

This research received no external funding.